UPDATE : Wednesday, August 21, 2019
상단여백
Psomagen seeks KOSDAQ listing using technology exception policy by Jeong Sae-im 2019-07-10 15:20
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute by Jeong Sae-im 2019-07-10 12:44
'Teva's Fremanezumab improves migraine-related disorders, quality of life' by Lee Han-soo 2019-07-09 16:57
‘Doctors know medical data best’ by Kim Eun-young 2019-07-09 16:07
ISU Abxis, Kyungpook National University to co-develop Alzheimer's disease treatment by Lee Han-soo 2019-07-09 16:06
라인
Sanofi Aventis names new general manager for consumer healthcare by Lee Han-soo 2019-07-09 15:16
GSK's Alitoc becoming salvation treatment for chronic hand eczema patients by Lee Han-soo 2019-07-09 14:44
Kolon files administrative suit against Invossa license revocation by Jeong Sae-im 2019-07-09 11:47
SillaJen shareholders panic over exec’s selling of 160,000 stocks by Jeong Sae-im 2019-07-09 11:45
SNUH to transfer advanced clinical trial capability to Saudi Arabia by Lee Han-soo 2019-07-08 16:44
라인
61% of doctors oppose telemedicine; survey by Song Soo-youn 2019-07-08 16:39
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance by Lee Hye-seon 2019-07-08 16:39
St. Mary's introduces Korea's 1st digital pathology solution by Lee Han-soo 2019-07-08 16:38
Eutilex wins patent for immunotherapy in Australia by Lee Han-soo 2019-07-08 14:27
Kolon TissueGene’s ₩490 billion shares on verge of becoming worthless by Jeong Sae-im 2019-07-08 12:06
라인
Yuhan invests ₩6 billion in Imnewrun Biosciences by Lee Han-soo 2019-07-08 12:05
Vuno's dementia diagnosis medical device wins certification by Lee Han-soo 2019-07-05 17:43
Dong-A ST, Dongwha Pharm lose status of innovative drugmaker by Jeong Sae-im 2019-07-05 16:00
Lilly aims to reshape Korea’s breast cancer treatment market by Lee Han-soo 2019-07-05 16:00
Victims question Kolon CEO’s sincerity in apology by Jeong Sae-im 2019-07-05 15:14
여백
여백
여백
Back to Top